Catalyst Wire Dossier Catalyst Wire Dossier

extended-release naltrexone

naltrexone
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for extended-release naltrexone, covering 2018-01-19 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder [Phase 2, Phase 3]

See pricing